Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts

Journal of Immunology

Volumn 164, Issue 9, 2000, Pages 4775-4782

  Cerboni, Cristina ^a   Mousavi Jazi, Mehrdad ^a,b   Linde, Annika ^b,c   Söderström, Kalle ^a   Brytting, Maria ^a,b   Wahren, Britta ^a,b   Kärre, Klas ^a   Carbone, Ennio ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL SURFACE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0034194223     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.9.4775     Document Type: Article

References (42)

1. Mocarski, E. S., Jr. 1996. Cytomegaloviruses and their replication. In Virology, Vol. 2. B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus, eds. Lippincott Raven, Philadelphia, p. 2447.
2. Biron, C. A., K. S. Byron, and J. S. Sullivan. 1989. Severe herpes virus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731.
3. Bukowski, J. F., J. F. Warner, G. Dennert, and R. M. Welsh. 1985. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J. Exp. Med. 161:40.
4. Bukowski, J. P., B. A. Woda, and R. M. Welsh. 1984. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52:119.
5. Scalzo, A. A., A. Fitzgerald, A. Simmons, A. B. La Vista, and G. R. Shellam. 1990. CMV-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med. 171:1469.
6. Forbes, C. A., M. G. Brown, R. Cho, G. R. Shellam, W. M. Yokoyama, and A. A. Scalzo. 1997. The Cmv1 host resistance locus is closely linked to the Ly49 multigene family within the natural killer cell gene complex on mouse chromosome 6. Genomics 41:406.
7. Scalzo, A. A., N. A. Fitzgerald, C. R. Wallance, A. E. Gibbons, W. M. Cheng Smart, R. C. Burton, and G. R. Shellam. 1992. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J. Immunol. 149:581.
8. Tay, C. H., and R. M. Welsh. 1997. Distinct organ dependent mechanism for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71: 267.
9. Lanier, L. L., B. Corliss, and J. H. Phillips. 1997. Arousal and inhibition of human NK cells. Immunol. Rev. 155:145.
10. Leong, C. C., T. L. Chapman, P. J. Bjorkman, D. Formankova, E. S. Mocarski, J. H. Phillips, and L. L. Lanier. 1998. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and viral class I homolog. J. Exp. Med. 10:1681.
11. Fletcher, J. M., H. G. Prentice, and J. E. Grundy. 1998. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function associated antigen-3 (LFA-3) expression and not with the CMV induced down regulation of cell surface class I HLA. J. Immunol. 161:2365.
12. Ljunggren, H. G., and K. Kärre. 1990. In search of the missing self: MHC molecules and NK cell recognition. Immunol. Today 11:237.
13. Ploegh, H. L. 1998. Viral strategies of immune evasion. Science 280:248.
14. Kärre, K., and R. M. Welsh. 1997. Viral decoy vetoes killer cell. Nature 386:446.
15. Beck, S., and B. G. Barrell. 1988. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 331:269.
16. Fahnestock, M. L., J. L. Johnson, R. M. R. Feldman, J. M. Neveu, W. S. Lane, and P. J. Bjorkman. 1995. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 3:583.
17. Reyburn, H. T., O. Mandelboim, M. Vales-Gomez, D. M. Davis, L. Pazmany. and J. L. Strominger. 1997. The class I MHC homotogue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514.
18. Farrell, H. E., H. Vally, D. M. Lynch, P. Fleming, G. R. Shellam, A. A. Scalzo, and N. J. Davis-Poynter. 1997. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386:510.
19. Cretney, E., M. P. Degli-Esposti, E. H. Densley, H. E. Farrell, N. J. Davis-Poynter, and M. J. Smyth. 1999. ml44, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J. Exp. Med. 190:435.
20. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and M. L. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273.
21. Cosman, D., N. Fanger, and L. Borges. 1999. Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers. Immunol. Rev. 168:177.
22. Fanger, N. A., L. Borges, and D. Cosman. 1999. The leukocyte immunoglobulin-like receptors (LIRs): a new family of immune regulators. J. Leukocyte Biol. 66:231.
23. Colonna, M., F. Navarro F., T. Bellòn, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopez-Botet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186:1809.
24. Borges, L., M. L. Hsu, N. Fanger, M. Kubin, and D. Cosman, D. 1997. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J. Immunol. 159:5192.
25. + NK cell clones. Int. Immunol. 11:29.
26. Cha, T., E. Tom, G. W. Kemble, G. M. Duke, E. S. Mocarsky, and R. R. Spaete. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:78.
27. Salter, R. D., and P. Creswell. 1986. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB hybrid. EMBO J. 5:943.
28. Perussia, B., C. Ramoni, I. Anegon, M. C. Cuturi, J. Faust, and G. Trinchieri. 1987. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. Nat. Immun. Cell Growth Regul. 6:171.
29. Fanger, N. A., D. Cosman, L. Pelerson, S. C. Braddy, C. R. Maliszewski, and L. Borges. 1998. The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur. J. Immunol. 28:3423.
30. Navarro, F., M. Llano, T. Bellon, M. Colonna, D.E. Geraghty, and M. Lopez-Botet. 1999. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 29:277.
31. Hamprecht, K., and M. Steinmassl. 1994. Low-dose human cytomegalovirus infection of human fibroblast cultures induces lymphokine-activated killer cell resistance: interferon β mediated target cell protection does not correlate with upregulation of HLA class I surface molecules. Immunology 82:171.
32. Bandyopadhyay, S., S. H. Oh, S. Michelson, D. S. Miller, J. L. Virelizier, and S. E. Starr. 1988. Natural killing of fibroblasts infected with low-passage clinical isolates of human cytomegalovirus. Clin. Exp. Immunol 73:11.
33. Penfold, M. E. T., D. J. Dairaghi, G. M. Duke, N. Saederup, E. S. Mocarski, G. W. Kemble, and T. J. Schall. 1999. Cytomegalovirus encodes a potent a chemokine. Proc. Natl. Acad. Sci. USA 96:9839.
34. Plotkin, S. A., and E. S. Huang. 1985. Cytomegalovirus vaccine virus (Towne strain) does not induce latency. J. Infect. Dis. 152:395.
35. Quinnan, G. V., M. Delery, A. H. Rook, W. R. Frederick, J. S. Epstein, S. F. Manischewitz, L. Jackson, K. M. Ramsey, K. Mittal, S. A. Plotkin, and M. R. Hilleman. 1984. Comparative virulence and immunogenicity of the Towne strain and a non attenuated strain of cytomegalovirus. Ann. Intern. Med. 101:478.
36. Elek, S. D., and H. Stern. 1974. Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero. Lancet 1:1.
37. Plotkin, S. A., J. Farquhar, and E. Hornberger. 1976. Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus. J. Infect. Dis. 134: 470.
38. Plotkin, S. A., H. M. Friedman, G. R. Fleisher, D. C. Dafoe, R. A. Grossman, M. L. Smiley, S. E. Starr, C. Wlodaver, A. D. Friedman, and C. F. Barker. 1984. Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants. Lancet 1:528.
39. Chapman, T. L., A. P. Heikema, and P. J. Bjorkman. 1999. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11:603.
40. Carbone, E., G. Terrazzano, M. Colonna, L. Tuosto, E. Piccolella, L. Franksson, G. Palazzolo, J. J. Perez-Villar, S. Fontana, K. Kärre, and S. Zappacosta. 1996. Natural killer clones recognize specific soluble HLA class I molecules. Eur. J. Immunol. 26:683.
41. 2. J. Immunol. 37:71.
42. Su, H. C., K. A. Leite-Morris, L. Braun, and C. A. Biron. 1991. A role for transforming growth factor pi in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus. J. Immunol. 147:2717.